Skip to main content
. 2022 Jun 12;107(8):2101–2128. doi: 10.1210/clinem/dgac278

Table 3.

Methodology for converting continuous subcutaneous insulin infusion to scheduled basal bolus insulin

Dosing suggestionsa
Basal insulin dose Prandial and/or correctional insulin doseb
Basal rate settings on pump known Refer to the pump’s active basal profile to determine the 24-hour basal insulin dose. Administer this dose as glargine U100 insulin as a single daily dose or in equally divided doses administered every 12 hours. For patients who perform CC at home, allow patients to continue using the settings provided in the pump’s active insulin profile for prandial and correctional insulin dosing.
For patients not using CC, use weight-based fixed premeal insulin doses (0.2 to 0.4 units/kg divided into 3 prandial insulin doses with correctional insulin administered for BG above target range.
For patients who are not eating, hold prandial insulin and continue correctional insulin dosing.
Basal rate settings on pump not known Calculate basal insulin dose of 0.2 to 0.4 units/kg per day administered as glargine U100 given as a single daily dose or in equally divided doses administered every 12 hours. Use weight-based fixed premeal insulin doses (0.2 to 0.4 units/kg divided into 3 prandial insulin doses).
Hold if patient is not eating.

Abbreviations: BG, blood glucose; CC, carbohydrate counting.

aBasal insulin should be administered 2 hours prior to discontinuation of insulin pump. Rapid-acting or regular insulin should be administered at least 30 minutes prior to discontinuation of an insulin pump.

bCorrectional insulin dosing can be administered before meals in addition to prandial insulin for patients who are eating or every 4 to 6 hours in patients who are not eating. For patients with a known correction factor, correction insulin may be prescribed as either a correction factor calculated toward a glucose target or a correction scale that uses a correction factor for the interval.